コメント (10)
トラックバックは利用できません。
Development of the IV formulation expanded use to critically ill and unable-to-swallow patients.
Concurrent use with statins metabolized by CYP3A4 increases risk of myopathy/rhabdomyolysis.
Diflucan may have in vitro synergy with flucytosine against some Candida species.
Diflucan is not recommended for treatment of fungal endocarditis.
Diflucan’s chemical structure gives it high water solubility.
Infusion-related reactions are rare, making rapid IV administration generally safe.
Headache and gastrointestinal disturbances are the most frequently reported adverse events.
It exhibits fungistatic, not fungicidal, activity against most susceptible species.
Often used for treating urinary tract infections caused by susceptible Candida species.
Diflucan is often used for esophageal candidiasis in immunocompromised hosts.
Development of the IV formulation expanded use to critically ill and unable-to-swallow patients.
Concurrent use with statins metabolized by CYP3A4 increases risk of myopathy/rhabdomyolysis.
Diflucan may have in vitro synergy with flucytosine against some Candida species.
Diflucan is not recommended for treatment of fungal endocarditis.
Diflucan’s chemical structure gives it high water solubility.
Infusion-related reactions are rare, making rapid IV administration generally safe.
Headache and gastrointestinal disturbances are the most frequently reported adverse events.
It exhibits fungistatic, not fungicidal, activity against most susceptible species.
Often used for treating urinary tract infections caused by susceptible Candida species.
Diflucan is often used for esophageal candidiasis in immunocompromised hosts.